menu-close-icon
Your using an unsupported browser. Please update to a modern browser for a better experience.
Skip to content
Clario Clario
  • Solutions
    • Study Endpoints
        • Cardiac safety and efficacy endpoint solutions for all phases, anywhere in the world.

        • Collect continuous ECG data in site-based or hybrid trials with our flexible solutions and patient-friendly devices.

        • Collect and centrally analyze accurate, consistent, quality blood pressure data from site-based to hybrid trials.

        • Monitor every heartbeat with precision to assess safety and efficacy throughout your site-based or hybrid clinical trial.

        • Fulfill your ICH E14 requirement early, minimize risk and potentially reduce costs throughout your trial.

        • Leverage our key opinion leaders to understand the complex regulatory landscape while minimizing risk with confidence.

        • Make your clinical trials easier, faster, more engaging and accessible to all.

        • Deliver reliable, scalable, and regulatory-ready eCOA for global Central Nervous System (CNS) trials.

        • Accelerate your clinical trial setup with Clario’s pre-validated and configured eCOA assessments.

        • Expert guidance for capturing high-quality, regulatory compliant data from the right participants, at the right time, in clinic or at home.

        • Improve data accuracy and reduce variability in scoring with Clario’s training solutions.

        • Your trusted partner for the richest eCOA endpoint data in your clinical trial.

        • Monitor Suicide Ideation and Behavior (SIB) in clinical trials effectively with Clario’s suicide assessment tool, eC-SSRS.

        • Enjoy flexible, fast and confidential site assessments at home.

        • Enhance your ePRO data with photo and audio capture.

        • Accelerate drug development and reduce risk with Clario’s comprehensive medical imaging core lab services.

        • The Clario team includes medical imaging experts and globally recognized key opinion leaders (KOLs) representing multiple disciplines.

        • Clario’s Image Redact AI automatically redacts sensitive patient identifiers from videos, photos and PDFs.

        • Secure accurate results, streamline your processes, and meet your unique needs with our imaging platform.

        • Leverage our full range of medical imaging and diagnostic imaging modalities, including CT Scans, Endoscopy, MRIs, and more.

        • Securely collect, store, and share de-identified images for compliance with 21 CFR Part 11 and EU GDPR standards.

        • Clario's complete solution for measuring objective digital endpoints of mobility with wearable sensor technology.

        • The Opal V2R® is a research grade wearable sensor that delivers meaningful outcomes and richer insights.

        • Explore more than 750 scientific publications that reflect the technical and clinical applications of Clario’s Opal® System.

        • Everything you need for high quality, low variability pulmonary function data and high patient compliance for clinical trials.

        • Improve your data quality, monitor for proper technique and leverage the power of AI to make interpretation of spirometry tests easier, faster and more consistent.

        • Centralized, on-site pulmonary function testing for clinical trials.

        • Remote spirometry testing for respiratory clinical trials.

        • Assess cough frequency, cough severity and other lung sounds such as crackles or rhonchi for clinical trials.

        • Assess the capacity of the lungs for effective gas transfer.

        • Advanced, cloud-native technologies and clinical trial software to screen, clean, QC and assess complicated data.

        • Collect, centralize and manage participant screening and eligibility data with customized workflows.

        • Boost stakeholder insights with business intelligence (BI) tools, analytics for endpoint and safety risks, and data exchange solutions.

        • Securely collect, store and share compliant images in the cloud to keep clinical trial sponsors and labs informed.

    • Segments
    • Study Phases
    • Technology
  • Therapeutic Areas
    • Cardiovascular & Metabolic Icon RGBCardiovascular & Metabolic
    • Dermatology Icon RGBDermatology
    • Type 2 Diabetes and Obesity iconDiabetes and Obesity
    • Gastroenterology Icon RGBGastroenterology
    • Hepatology Icon RGBHepatology
    • Infectious Disease Icon RGBInfectious Diseases
    • Muskoskeletal Icon RGBMusculoskeletal
    • Neuroscience Icon RGBNeuroscience
      • Neuroscience Indications
    • Oncology Icon RGBOncology
    • Ophthalmology Icon RGBOphthalmology
    • Respiratory Solutions IconRespiratory
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Careers
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Newsroom
    • Scientific Expertise
    • Strategic Partnerships
    • Values and Culture
  • Support
    • Customer Support
    • In-Country Customer Support
  • Solutions
    • Study Endpoints
      • Cardiac Solutions
        • Cardiac Solutions
        • Arrhythmia Analysis
        • Blood Pressure Services
        • ECG — On-site to DCT and Phase I-IV
        • Phase I/TQT Cardiac Assessment
        • Regulatory Consultation and Statistical Analysis Expertise
      • Clinical Adjudication
      • eCOA
        • eCOA Clinical Trials
        • eCOA Neuroscience
        • eCOA Rapid Start
        • eCOA Science Services
        • eCOA Rater and Participant Training
        • eCOA Rescue Studies
        • Suicidal Ideation
        • eCOA Live
        • eCOA Multimedia
      • Medical Imaging
        • Medical Imaging
        • Image Redact AI
        • Imaging Platform
        • Medical Imaging Science Team
        • Modalities
        • SMART Submit
      • Precision Motion
        • Precision Motion for Clinical Trials
        • Precision Motion for Research
        • Precision Motion: Scientific Publications
      • Respiratory Solutions
        • Respiratory Solutions
        • Respiratory Solutions for Healthcare Providers
        • Site-Based Spirometry
        • Virtual Home Spirometry
        • Cough and Lung Sounds
        • Diffusing Capacity (DLCO)
      • Trial Enablement
        • Trial Enablement
        • Eligibility Solution
        • Reporting & Analytics
        • Source Document Manager
    • Segments
      • Biotechs
      • CROs
      • Pharma
    • Study Phases
      • Phase I
      • Phase II/III
    • Technology
      • Artificial Intelligence (AI)
      • Hybrid Trials
  • Therapeutic Areas
    • Cardiovascular & Metabolic
    • Dermatology
    • Diabetes and Obesity
    • Gastroenterology
    • Hepatology
    • Infectious Diseases
    • Musculoskeletal
    • Neuroscience
      • Dementias
      • Headache Disorders
      • Movement Disorders
      • Multiple Sclerosis
      • Pain Disorders
      • Psychiatric Disorders
    • Oncology
    • Ophthalmology
    • Respiratory
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Scientific Expertise
    • Strategic Partnerships
    • Values and Culture
  • Support
    • Customer Support
    • In-Country Customer Support
  • Careers
    • Life at Clario
  • Newsroom
  • Login
  • Contact sales
    • Log in
    • Get started
  1. Home Resources Downloads Clinical evaluation of artificial intelligence supported software in the interpretation of spirometry results in a primary care setting

Clinical evaluation of artificial intelligence supported software in the interpretation of spirometry results in a primary care setting

Rationale: Few primary care physicians perform spirometry tests or interpret spirometry results themselves. This results in assessments of chronic respiratory disease diagnoses not in line with guidelines and might lead to less time- and cost-effective secondary care visits. Since the interpretation of spirometry tests heavily relies on pattern recognition, AI-based software could potentially provide support to GPs performing spirometry testing. While previous studies demonstrated the added value of AI for the interpretation of full pulmonary function testing (PFT), this study aims to investigate the accuracy of GP assessment of spirometry curves alone with and without the use of the provided AI-supported software, ArtiQ.Spiro.

Methods: A total of 6 primary care practices in Belgium used ArtiQ.Spiro, during a 3-month period alongside existing referral structures.

The accuracy of the diagnostic hypothesis based on the clinical evaluation and interpretation of spirometry, supported by the AI software, was established by comparison to the diagnosis made by an expert panel of 3 pulmonologists. This panel reviewed the same data and all relevant information from the patient record 3 months after the spirometry session.  

Results: In 77% of cases, GPs agreed with the diagnosis proposed by ArtiQ.Spiro. Combined with spirometry and AI support, GPs labeled patients correctly in 67% of patients. When comparing the AI-proposed diagnosis with the pulmonologists’ diagnosis, 82% of diagnoses were correct.

Conclusion: GPs often don’t perform and interpret spirometry consistently. AI has been proven to provide highly accurate diagnosis support as compared to pulmonologist opinion. As such, the investigated AI-based software should increase the diagnostic accuracy of chronic respiratory diseases in a primary care setting. Further research should focus on how to further improve the GP’s use of and collaboration with AI tools.

Authors: Authors: Willaert S.1, Maes J.2, De Vos M. 1,3, Topalovic M.2, Verbakel J. Y.1,4 

Affiliations:

1. Department of Public Health and Primary Care, KU Leuven, KU Leuven, Leuven, Belgium 

2. ArtiQ NV, Leuven, Belgium 

3. Department of Electrical Engineering, KU Leuven, Leuven, Belgium 

4. NIHR Community Healthcare Medtech and IVD cooperative, Nuffield Department of Primary Care Health Sciences, University of Oxford, UK 

Download
Back to downloads
Share
Twitter Facebook LinkedIn

Latest Downloads

See all
Datasheet

Centralized FOT Services

Download icon Download icon
Download
White Paper

AI-enabled risk based monitoring – Cardiac Safety

Download icon Download icon
Download
White Paper

AI-enabled risk-based monitoring – Respiratory

Download icon Download icon
Download
Checklist

Top 5 questions biotech companies should ask to enable study success

Read icon Read icon
Read
Clario logo
    • Solutions
    • Therapeutic Areas
    • About
    • Resources
    • Careers
    • Newsroom
  • Get in touch

    • Contact
    • Support
    • Customer portal

Follow us

Twitter LinkedIn Glassdoor
×

Get started

If you are looking for a partner to help you generate the richest clinical evidence with the right clinical trial technology, please fill in the form below.

Step 1 of 2 - Quick and easy to complete

Not what you're looking for?

Please visit our Contact Page for customer support, office locations, or media contacts.

  • © 2026 Clario

    • Legal and Privacy Terms
    • Information Security
    • Cookie Policy
    • Impressum